Johnson & Johnson to test coronavirus vaccine in 60,000 volunteers
Coronavirus chronicle
20 August, 2020, 09:55 pm
Last modified: 20 August, 2020, 09:56 pm
Shares of the company rose marginally on Thursday, paring their earlier losses, after the Wall Street Journal first reported the news
FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, US, September 17, 2019. REUTERS/Brendan McDermid/File Photo
Johnson & Johnson aims to test its experimental coronavirus vaccine in up to 60,000 volunteers in a late-stage trial scheduled to start in September, according to a US government database of clinical trials.
Shares of the company rose marginally on Thursday, paring their earlier losses, after the Wall Street Journal first reported the news.
Rival coronavirus vaccine makers such as Moderna Inc and Pfizer are targeting recruiting up to 30,000 volunteers for their late-stage studies.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.